We are live on ! Find out more
VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
+6.98%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$368M
AUM Growth
+$18.7M
Cap. Flow
+$14.9M
Cap. Flow %
4.04%
Top 10 Hldgs %
6.4%
Holding
553
New
113
Increased
199
Reduced
149
Closed
92

Top Buys

Rank Stock Value
1
EXPD icon
Expeditors International
EXPD
+$2.17M
2
INCY icon
Incyte
INCY
+$2.09M
3
WAT icon
Waters Corp
WAT
+$2.03M
4
AMAT icon
Applied Materials
AMAT
+$2.01M
5
LVS icon
Las Vegas Sands
LVS
+$2.01M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$2.5M
2
EA
Electronic Arts
EA
+$2.43M
3
FOXA icon
Fox Class A
FOXA
+$2.05M
4
MS icon
Morgan Stanley
MS
+$2.04M
5
ATO icon
Atmos Energy
ATO
+$2.02M

Sector Composition

Rank Sector Weight
1 Healthcare 26.73%
2 Financials 22.73%
3 Technology 18.16%
4 Industrials 8.89%
5 Consumer Discretionary 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KIO
201
KKR Income Opportunities Fund
KIO
$457M
$654K 0.18%
56,409
-17,122
-23% -$203K
KALV
202
DELISTED
KalVista Pharmaceuticals
KALV
$653K 0.18%
40,414
+31,721
+365% +$420K
ONC
203
BeOne Medicines Ltd
ONC
$39.4B
$650K 0.18%
2,141
+534
+33% +$175K
TGTX icon
204
TG Therapeutics
TGTX
$7.62B
$650K 0.18%
21,799
+9,907
+83% +$324K
ARWR icon
205
Arrowhead Research
ARWR
$12.4B
$647K 0.18%
9,749
+2,734
+39% +$134K
IMCR icon
206
Immunocore
IMCR
$1.73B
$645K 0.18%
18,569
+6,097
+49% +$215K
RYTM icon
207
Rhythm Pharmaceuticals
RYTM
$7.96B
$644K 0.18%
6,017
-1,035
-15% -$110K
FDUS icon
208
Fidus Investment
FDUS
$772M
$643K 0.17%
33,322
-6,522
-16% -$130K
ARDX icon
209
Ardelyx
ARDX
$997M
$642K 0.17%
110,048
-9,413
-8% -$52.4K
BGT icon
210
BlackRock Floating Rate Income Trust
BGT
$325M
$641K 0.17%
56,588
-10,575
-16% -$122K
NBIX icon
211
Neurocrine Biosciences
NBIX
$16.6B
$634K 0.17%
4,472
+917
+26% +$133K
CRSP icon
212
CRISPR Therapeutics
CRSP
$5.17B
$632K 0.17%
12,056
+1,291
+12% +$77.3K
HRMY icon
213
Harmony Biosciences
HRMY
$2.24B
$631K 0.17%
16,869
+3,536
+27% +$116K
HTGC icon
214
Hercules Capital
HTGC
$3.23B
$631K 0.17%
33,518
-7,478
-18% -$135K
ADMA icon
215
ADMA Biologics
ADMA
$2.22B
$630K 0.17%
34,551
+13,977
+68% +$236K
CRNX icon
216
Crinetics Pharmaceuticals
CRNX
$8.92B
$630K 0.17%
13,535
+9,998
+283% +$445K
GBDC icon
217
Golub Capital BDC
GBDC
$3.42B
$623K 0.17%
45,915
-11,678
-20% -$162K
INSM icon
218
Insmed
INSM
$28.6B
$604K 0.16%
3,468
-1,119
-24% -$204K
LENZ
219
LENZ Therapeutics
LENZ
$168M
$603K 0.16%
37,674
+33,827
+879% +$986K
EVF
220
Eaton Vance Senior Income Trust
EVF
$90.5M
$602K 0.16%
114,242
-44,549
-28% -$240K
BXSL icon
221
Blackstone Secured Lending
BXSL
$5.72B
$599K 0.16%
22,739
-2,977
-12% -$79.9K
EFT
222
Eaton Vance Floating-Rate Income Trust
EFT
$288M
$598K 0.16%
52,944
-16,191
-23% -$186K
GLAD icon
223
Gladstone Capital
GLAD
$446M
$587K 0.16%
28,401
+10,703
+60% +$217K
FSCO
224
FS Credit Opportunities Corp
FSCO
$1.02B
$587K 0.16%
93,096
+3,545
+4% +$22.7K
DSU icon
225
BlackRock Debt Strategies Fund
DSU
$597M
$585K 0.16%
57,419
-20,813
-27% -$214K
7 8
9
10 11

Similar funds

RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
HS
HighVista Strategies Boston, Massachusetts $362M AUM 230.96% 1-Year Est. Return
SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

Virtus Investment Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, Virtus Investment Advisers held 553 positions worth $368M, up 5.3% from $349M the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Virtus Investment Advisers deployed $14.9M of net new capital in Q4 2025, opening 113 new positions and adding to 199 existing holdings. Its largest new stake was Expeditors International: 15,974 shares worth $2.38M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was VICI Properties, an estimated $1.66M trimmed.

  • Virtus Investment Advisers's largest Q4 2025 buy was Expeditors International: 15,974 shares worth $2.38M.
  • Virtus Investment Advisers added most to Incyte in Q4 2025, an estimated $2.09M increase.
  • Virtus Investment Advisers's biggest Q4 2025 reduction was VICI Properties, cutting an estimated $1.66M.
  • Virtus Investment Advisers fully exited Tesla in Q4 2025, selling an estimated $2.5M.
  • Virtus Investment Advisers's ten largest holdings make up 6.4% of its $368M portfolio in Q4 2025.
  • Virtus Investment Advisers opened 113 new positions and closed 92 in Q4 2025.
  • Virtus Investment Advisers's portfolio value rose 5.3% quarter-over-quarter to $368M.

Based on Virtus Investment Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.